Chronic pain is at an epidemic level in the United States. Many types of chronic pain are very difficult to diagnosis and treat, as it can be a genetic code mutation (hereditary), the result of another underlying cause, or progressive or chronic Peripheral Neuropathy. A new neurotheraphy has been helping Peripheral Neuropathy sufferers across the globe alleviate advanced cases of pain by a non-invasive FDA cleared electrostimulation therapy: The Calmare Pain Therapy treatment.

Who is the best candidate for The Calmare Pain Therapy treatment?

The Calmare Pain Therapy treatment is for patients with peripheral neuropathy who have stopped, or have not responded to traditional medical treatments. Medications and prescribed therapies can only mask the pain so long with progressive peripheral neuropathies. The cause of the pain is not addressed and as medicinal tolerance builds, or the pain worsens, alternative treatment must be sought. Cancer pain can be resistant to morphine and high-intensity chronic pain can be very agonizing and The Calmare device uses a biophysical over biochemical approach by the uses of surface electrodes that transmit a “no-pain” signal that overrides the actual pain signal sent through the body to the brain.

The Calmare Pain Therapy treatment strategy for peripheral neuropathy is an approach using neuromodulative electrical stimulus to “scramble” the pain information to the brain, resulting in a reduction of intensity in the signal and the body’s perception of its pain. Within 2 weeks an average of 76% of peripheral neuropathy patients in a recent Italian study showed a clear reduction of chronic pain in patients with, and without, cancer. This is quite a breakthrough for people living with daily, chronic pain and its treatment. Cutaneous electrostimulation by the Calmare Pain Therapy approach was successful in greatly lessening pain for patients with peripheral neuropathy.

Who should not use The Calmare Pain Therapy treatment?

The NCBI also reports that there are “sham machines”’ and they are not effective and may cause more permanent nerve damage, or be ineffective altogether. Patients with Pacemakers or Defibrillators cannot use The Calmare Therapy as the machines are incompatible with Calmare. Patients taking Neurontin or Lyrica are discouraged from integrating Calmare with the medication, as it will not be a true read of the pain signals as the medication affects these signals and their perception to the brain.

The Calmare Pain Therapy is not for arthritis or general muscle pain or soreness of the muscles. It is most effective in a discrete body location, such as the leg or arm, and larger vast areas have less success. Fibromyalgia patients may not have as much success in total pain elimination as a surgical patient for instance.